Drug Profile
Tarenflurbil spraygel - MIKA Pharma
Alternative Names: MIKA-tarenflurbil-spraygel; MK-50Latest Information Update: 02 May 2016
Price :
$50
*
At a glance
- Originator PAZ GmbH
- Developer MIKA Pharma GmbH
- Class Antidementias; Antineoplastics; Biphenyl compounds; Propionic acids; Small molecules
- Mechanism of Action Amyloid precursor protein secretase modulators; NF-kappa B inhibitors; Transcription factor AP-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Inflammation; Pain; Skin disorders
Most Recent Events
- 02 May 2016 Chemical structure information added
- 27 Apr 2016 Development is ongoing in Germany